Molecular interactions of Bcl-2 and Bcl-xL with mortalin: Identification and functional characterization

Bioscience Reports

Volumn 33, Issue 5, 2013, Pages

  Saxena, Nishant ^a   Katiyar, Shashank P ^b   Liu, Ye ^a   Grover, Abhinav ^b   Gao, Ran ^a   Sundar, Durai ^b   Kaul, Sunil C ^a   Wadhwa, Renu ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Bcl 2; Bcl xL; Interaction; Mortalin; P53 activation; Senescence

Indexed keywords

CHAPERONE; MORTALIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BIOCHEMISTRY; BIOINFORMATICS; CANCER CELL; CELL AGING; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; BCL-X PROTEIN; CELL AGING; CELL LINE, TUMOR; GENE EXPRESSION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN BONDING; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS C-BCL-2; THERMODYNAMICS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84887037147     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20130034     Document Type: Article

References (50)

1. Petros, A. M., Olejniczak, E. T. and Fesik, S. W. (2004) Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644, 83-94
2. Thomadaki, H. and Scorilas, A. (2006) Bcl-2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit. Rev. Clin. Lab. Sci. 43, 1-67
3. Qian, J., Voorbach, M. J., Huth, J. R., Coen, M. L., Zhang, H., Ng, S. C., Comess, K. M., Petros, A. M., Rosenberg, S. H., Warrior, U. and Burns, D. J. (2004) Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms. Anal. Biochem. 328, 131-138
4. Huang, Z. (2000) Bcl-2 family proteins as targets for anticancer drug design. Oncogene 19, 6627-6631
5. Deng, X., Gao, F., Flagg, T. and May, W. S. , Jr. (2004) Mono- and multisite phosphorylation enhances Bcl-2's antiapoptotic function and inhibition of cell cycle entry functions. Proc. Natl. Acad. Sci. USA 101, 153-158
6. Ran, Q., Wadhwa, R., Kawai, R., Kaul, S. C., Sifers, R. N., Bick, R. J., Smith, J. R. and Pereira-Smith, O. M. (2000) Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75. Biochem. Biophys. Res. Commun. 275, 174-179
7. Liu, Y., Liu, W., Song, X. D. and Zuo, J. (2005) Effect of GRP75/mthsp70/PBP74/mortalin overexpression on intracellular ATP level, mitochondrial membrane potential and ROS accumulation following glucose deprivation in PC12 cells. Mol. Cell. Biochem. 268, 45-51
8. Kaul, S. C., Reddel, R. R., Sugihara, T., Mitsui, Y. and Wadhwa, R. (2000) Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2. FEBS Lett. 474, 159-164
9. Kaul, S. C., Yaguchi, T., Taira, K., Reddel, R. R. and Wadhwa, R. (2003) Overexpressed mortalin (mot-2)/mthsp70/GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts. Exp. Cell Res. 286, 96-101
10. Xu, L., Voloboueva, L. A., Ouyang, Y., Emery, J. F. and Giffard, R. G. (2009) Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab. 29, 365-74
11. Kaul, S. C., Duncan, E. L., Englezou, A., Takano, S., Reddel, R. R., Mitsui, Y. and Wadhwa, R. (1998) Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein. Oncogene 17, 907-911
12. Wadhwa, R., Takano, S., Kaur, K., Deocaris, C. C., Pereira-Smith, O. M., Reddel, R. R. and Kaul, S. C. (2006) Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int. J. Cancer 118, 2973-2980
13. Yokoyama, K., Fukumoto, K., Murakami, T., Harada, S., Hosono, R., Wadhwa, R., Mitsui, Y. and Ohkuma, S. (2002) Extended longevity of Caenorhabditis elegans by knocking in extra copies of hsp70F, a homolog of mot-2 (mortalin)/mthsp70/Grp75. FEBS Lett. 516, 53-57
14. Wadhwa, R., Ando, H., Kawasaki, H., Taira, K. and Kaul, S. C. (2003) Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes. EMBO Rep. 4, 595-601
15. Wadhwa, R., Takano, S., Taira, K. and Kaul, S. C. (2004) Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells. J. Gene Med. 6, 439-444
16. Kimura, K., Tanaka, N., Nakamura, N., Takano, S. and Ohkuma, S. (2007) Knockdown of mitochondrial heat shock protein 70 promotes progeria-like phenotypes in Caenorhabditis elegans. J. Biol. Chem. 282, 5910-5918
17. Wadhwa, R., Takano, S., Robert, M., Yoshida, A., Nomura, H., Reddel, R. R., Mitsui, Y. and Kaul, S. C. (1998) Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J. Biol. Chem. 273, 29586-29591
18. Kaul, S. C., Aida, S., Yaguchi, T., Kaur, K. and Wadhwa, R. (2005) Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides. J. Biol. Chem. 280, 39373-39379
19. Ma, Z., Izumi, H., Kanai, M., Kabuyama, Y., Ahn, N. G. and Fukasawa, K. (2006) Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene 25, 5377-5390
20. Lu, W. J., Lee, N. P., Kaul, S. C., Lan, F., Poon, R. T., Wadhwa, R. and Luk, J. M. (2011) Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death Differ. 18, 1046-1056
21. Lu, W. J., Lee, N. P., Kaul, S. C., Lan, F., Poon, R. T. P., Wadhwa, R. and Luk, J. M. (2011) Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. Int. J. Cancer 129, 1806-1814
22. Bruschi, S. A. and Lindsay, J. G. (1994) Mitochondrial stress protein actions during chemically induced renal proximal tubule cell death. Biochem. Cell Biol. 72, 663-667
23. Qu, M., Zhou, Z., Xu, S., Chen, C., Yu, Z. and Wang, D. (2011) Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells. Brain Res. 1368, 336-345
24. Mihara, M. and Moll, U. M. (2003) Detection of mitochondrial localization of p53. Methods Mol. Biol. 234, 203-209
25. Deng, X., Gao, F., Flagg, T., Anderson, J. and May, W. S. (2006) Bcl2's flexible loop domain regulates p53 binding and survival. Mol. Cell Biol. 26, 4421-4434
26. Petros, A. M., Gunasekera, A., Xu, N., Olejniczak, E. T. and Fesik, S. W. (2004) Defining the p53 DNA-binding domain/Bcl-xL-binding interface using NMR. FEBS Lett. 559, 171-174
27. Jung, M. S., Jin, D. H., Chae, H. D., Kang, S., Kim, S. C., Bang, Y. J., Choi, T. S., Choi, K. S. and Shin, D. Y. (2004) Bcl-xL and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation. J. Biol. Chem. 279, 17765-17771
28. Fiser, A. and Sali, A. (2003) Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol. 374, 461-491
29. Dominguez, C., Boelens, R. and Bonvin, A. M. (2003) HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125, 1731-1737
30. Negi, S. S., Schein, C. H., Oezguen, N., Power, T. D. and Braun, W. (2007) InterProSurf: a web server for predicting interacting sites on protein surfaces. Bioinformatics 23, 3397-3399
31. Reynolds, C., Damerell, D. and Jones, S. (2009) ProtorP: a protein-protein interaction analysis server. Bioinformatics 25, 413-414
32. Desmond Molecular Dynamics System (2010) Version 2.4, D.E. Shaw Research, New York, NY, 2010. Maestro-Desmond Interoperability Tools, Version 2.4, Schrödinger, New York, NY
33. Humphrey, W., Dalke, A. and Schulten, K. (1996) VMD-visual molecular dynamics'. J. Mol. Graphics 14, 33-38
34. Rudiger, S., Germeroth, L., Schneider-Mergener, J. and Bukau, B. (1997) Substrate specificity of the DnaK chaperone determined by screening cellulose-bound peptide libraries. EMBO J. 16, 1501-1507
35. Walker, C., Bottger, S. and Low, B. (2006) Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model. Am. J. Pathol. 168, 1526-1530
36. Wadhwa, R., Yaguchi, T., Hasan, M. K., Mitsui, Y., Reddel, R. R. and Kaul, S. C. (2002) Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp. Cell Res. 274, 246-253
37. Bertram, M. J., Berube, N. G., Hang-Swanson, X., Ran, Q., Leung, J. K., Bryce, S., Spurgers, K., Bick, R. J., Baldini, A., Ning, Y. et al. (1999) Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol. Cell Biol. 19, 1479-1485
38. Nakabayashi, K., Ogata, T., Fujii, M., Tahara, H., Ide, T., Wadhwa, R., Kaul, S. C., Mitsui, Y. and Ayusawa, D. (1997) Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp. Cell Res. 235, 345-353
39. Wadhwa, R., Sugihara, T., Yoshida, A., Nomura, H., Reddel, R. R., Simpson, R., Maruta, H. and Kaul, S. C. (2000) Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res. 60, 6818-6821
40. Widodo, N., Deocaris, C. C., Kaur, K., Hasan, K., Yaguchi, T., Yamasaki, K., Sugihara, T., Ishii, T., Wadhwa, R. and Kaul, S. C. (2007) Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway. J. Gerontol. A Biol. Sci. Med. Sci. 62, 246-255
41. Widodo, N., Kaur, K., Shrestha, B. G., Takagi, Y., Ishii, T., Wadhwa, R. and Kaul, S. C. (2007) Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin. Cancer Res 13, 2298-2306
42. Grover, A., Priyandoko, D., Gao, R., Shandilya, A., Widodo, N., Bisaria, V. S., Kaul, S. C., Wadhwa, R. and Sundar, D. (2012) Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence. Int. J. Biochem. Cell Biol. 44, 496-504
43. Kim, R. (2005) Unknotting the roles of Bcl-2 and Bcl-xL in cell death. Biochem. Biophys. Res. Commun. 333, 336-343
44. Shinoura, N., Yoshida, Y., Nishimura, M., Muramatsu, Y., Asai, A., Kirino, T. and Hamada, H. (1999) Expression level of Bcl-2 determines anti- or proapoptotic function. Cancer Res. 59, 4119-4128
45. Watanabe, J., Kushihata, F., Honda, K., Sugita, A., Tateishi, N., Mominoki, K., Matsuda, S. and Kobayashi, N. (2004) Prognostic significance of Bcl-xL in human hepatocellular carcinoma. Surgery 135, 604-612
46. Knowlton, K., Mancini, M., Creason, S., Morales, C., Hockenbery, D. and Anderson, B. O. (1998) Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect. J. Surg. Res. 76, 22-26
47. Kumazaki, T., Sasaki, M., Nishiyama, M., Teranishi, Y., Sumida, H., Eboshima, A. and Mitsui, Y. (2003) Life span shortening of normal fibroblasts by overexpression of BCL-2: a result of potent increase in cell death. Exp. Cell Res. 285, 299-308
48. Borner, C. (1996) Diminished cell proliferation associated with the death protective activity of Bcl-2. J. Biol. Chem. 271, 12695-12698
49. Mazel, S., Burtrum, D. and Petrie, H. T. (1996) Regulation of cell division cycle progression by Bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183, 2219-2226
50. Vairo, G., Innes, K. M. and Adams, J. M. (1996) Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 13, 1511-1519